Investor Relations


MyoKardia is a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

Read More

Recent Press Releases

NASDAQ GS | MYOK (Common Stock)
$49.05 + 1.36
Stock chart for: MYOK.O.  Currently trading at $49.05 with a 52 week high of $67.79 and a 52 week low of $39.01.
10/26/184:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Upcoming Events

There are currently no events scheduled.